TITLE

Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases

AUTHOR(S)
Brocco, Stefano; Visentin, Cristiana; Fedeli, Ugo; Schievano, Elena; Avogaro, Angelo; Andretta, Margherita; Avossa, Francesco; Spolaore, Paolo
PUB. DATE
January 2007
SOURCE
Cardiovascular Diabetology;2007, Vol. 6, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: Diabetes mellitus is a growing public health problem, for which efficient and timely surveillance is a key policy. Administrative databases offer relevant opportunities for this purpose. We aim to monitor the incidence of diabetes and its major complications using administrative data. Study design and methods: We study a population of about 850000 inhabitants in the Veneto Region (Italy) from the end of year 2001 to the end of year 2004. We use four administrative databases with record linkage. Databases of drug prescriptions and of exemptions from medical charge were linked to identify diabetic subjects; hospital discharge records and mortality data were used for the assessment of macrovascular and renal complications and vital status. Results: We identified 30230 and 34620 diabetic subjects at the start and at the end of the study respectively. The row prevalence increased from 38.3/1000 (95% CI 37.2 - 39.5) to 43.2/1000 (95% CI 42.3 - 44) for males and from 34.7/1000 (95% CI 33.9 - 35.5) to 38.1/1000 (95% CI 37.4 - 39) for females. The mean row incidence is 5.3/1000 (95% CI 5 - 5.6) person years for males and 4.8/ 1000 (95% CI 4.4 - 5.2) person years for females. The rate of hospitalisations for cardiovascular or kidney diseases is greatly increased in diabetic people with respect to non diabetics for both genders. The mortality relative risk is particularly important in younger age classes: diabetic males and females aged 45-64 years present relative risk for death of 1.7 (95% CI 1.58 - 1.88) and 2.6 (95% CI 2.29 - 2.97) respectively. Conclusion: This study provides a feasible and efficient method to determine and monitor the incidence and prevalence of diabetes and the occurrence of its complications along with indexes of morbidity and mortality.
ACCESSION #
28682838

 

Related Articles

  • Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus. Profit, Louise; Chrisp, Paul; Nadin, Carole // Core Evidence;2008, Vol. 3 Issue 1, p14 

    Introduction: Type 2 diabetes is increasing in prevalence worldwide and is a leading cause of morbidity and mortality, mainly due to the development of complications. Vildagliptin is an inhibitor of dipeptidyl peptidase 4 (DPP-4), a new class of oral antidiabetic agents. Aims: To evaluate the...

  • Limiting and treating DM's chronic complications. Steil, Condit F. // Drug Topics;Oct99 Supplement Diabetes, Vol. 143 Issue 19, p14S 

    Discusses the limitation and treatment of diabetes mellitus' (DM) chronic complications. Information on the pathophysiologic changes associated with diabetes; Overview on the macrovascular and microvascular complications of DM.

  • The prevalence of known diabetes in eight European countries. Fleming, D. M.; Schellevis, F. G.; Van Casteren, V. // European Journal of Public Health;Mar2004, Vol. 14 Issue 1, p10 

    Background: The prevalence of diabetes has been proposed as a European Community Health Indicator. The prevalence of diabetes known to general practitioners (GPs) in different European countries has been investigated and the usefulness of sentinel practice networks in delivering prevalence data...

  • New concepts in managing diabetic foot infections. Leichter, Steven B.; Schaefer, John C.; O'Brian, John T. // Geriatrics;May1991, Vol. 46 Issue 5, p24 

    Recent enhanced attention to diabetic foot infection--in both clinical care and research--has yielded a modified picture of this disorder. It suggests that certain diabetic patients may have important risk factors for the development of infection, and further, infections in these patients may...

  • Case Study: Treating Hypertension in Patients With Diabetes. Benjamin, Evan M. // Clinical Diabetes;Summer2004, Vol. 22 Issue 3, p137 

    Presents a case study of cardiovascular complications in diabetes mellitus. Overview of a study of an anti-hypertensive treatment in patients with diabetes to reduce cardiovascular complications; Clinical briefs.

  • Current Concepts in Gastric Motility in Diabetes Mellitus. De Block, Christophe E. M.; De Leeuw, Ivo H.; Pelckmans, Paul A.; Van Gaal, Luc F. // Current Diabetes Reviews;2006, Vol. 2 Issue 1, p113 

    This review addresses the current concepts in our understanding of the epidemiology, mechanisms, symptoms, clinical consequences, diagnosis and treatment of delayed gastric emptying in patients with diabetes. Upper gastrointestinal symptoms, particularly postprandial fullness, nausea, vomiting...

  • What To Do--And Not Do--When A Loved One Has Diabetes. Wright, Hillary M. // Environmental Nutrition;Oct2005, Vol. 28 Issue 10, p1 

    Presents an article that discusses all about the diabetes disease. Identification of the kind of people who are very much susceptible to diabetes; Complications created by the disease; Guides on how to prevent the infliction of diabetes. INSET: Got TV? Got Computer? Get Info.

  • PGC-1a regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Valle, Inmaculada; �lvarez-Barrientos, Alberto; Arza, Elvira; Lamas, Santiago; Monsalve, Mar�a // Cardiovascular Research;Jun2005, Vol. 66 Issue 3, p562 

    Abstract: Objective: Mitochondrial production of oxidants contributes to a variety of pathological conditions including the vascular complications of diabetes, neurodegenerative diseases, and cellular senescence. We postulated that a transcriptional coactivator, peroxisome proliferator activated...

  • Diagnosis and Classification of Diabetes Mellitus.  // Diabetes Care;Jan2013 Supplement, Vol. 36 Issue S1, pS67 

    The article discusses the symptoms and complications of type 1 and type 2 diabetes. The report also mentions the other types of the disease including genetic defects in insulin action, endocrinopathies, and drug or chemical-induced diabetes. An overview of the etiologic classification of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics